Records containing: Rheumatoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-12-16Mechanisms of Antifolate Efficacy in Arthritis
-
CLINICAL_TRIALS study record update · 2016-12-15A National, Open-Label, Single-Arm, Phase IIIb Study to Evaluate the Efficacy of Weekly Tocilizumab Subcutaneous, Administered as Monotherapy or in Combination With Methotrexate and/or Other DMARDs in Rheumatoid Arthritis (RA) Patients
-
CLINICAL_TRIALS study record update · 2016-12-13A Long-Term Assessment of Safety and Physical Function With AMG 108 Subcutaneous Monthly Treatment in Subjects With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2016-12-13Retrospective Data Collection on Rheumatoid Arthritis (RA) Patients Treated With Rituximab in Finland.
-
CLINICAL_TRIALS study record update · 2016-12-08Safety of Disease Modifying Antirheumatic Drug (DMARD) and Biologic Treatment of Rheumatoid Arthritis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-08The Effects of High-Intensity Interval Training on Inflammation in Adults With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2016-12-02A Multi-Center, Non-Interventional Study to Evaluate Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab (ACROSS)
-
CLINICAL_TRIALS study record update · 2016-12-01Non-interventional Local Study to Describe the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-biologic DMARD
-
CLINICAL_TRIALS study record update · 2016-11-30Phase Ib Randomized, Double-Blind, Placebo-Controlled Study of Meriva in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2016-11-28Multi-center Prospective European Cohort Study in Patients With Rheumatoid Arthritis or Juvenile Idiopathic Arthritis Planned to be Treated Independently of the Present Study, With the First Line of Adalimumab, Etanercept, Infliximab Therapy or With Rituximab or Tocilizumab (After Anti-Tumor Necrosis Factor Therapy or Another Biotherapy or in First Line)
-
CLINICAL_TRIALS study record update · 2016-11-28A Multicenter, Open-Label Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2016-11-21A Randomized, Multi-Dose, Placebo-Controlled, Study of the Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2016-11-17Golimumab Intravenous Infusion Registry (GO-IV)
-
CLINICAL_TRIALS study record update · 2016-11-16Effect of a Thin Customized Insole on Pain and Walking Ability in Rheumatoid Arthritis: A Randomised Study
-
CLINICAL_TRIALS study record update · 2016-11-11A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
-
CLINICAL_TRIALS study record update · 2016-11-11Regulation of the Immune System in Response to the Treatment With Tocilizumab in RA Patients
-
CLINICAL_TRIALS study record update · 2016-11-11Ability To Achieve A Good Eular Response In Patients With Moderate-to-severe Active Early Rheumatoid Arthritis Who Satisfy The New Acr/Eular Classification Criteria Receiving Etanercept + Mtx In Real World Clinical Practice In Greece
-
CLINICAL_TRIALS study record update · 2016-11-09Open Label, Multicentric Phase IIIb Study to Evaluate the Effect of Tocilizumab in Combination With DMARDs in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Dedicated Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis (RA)
-
CLINICAL_TRIALS study record update · 2016-11-07ClinicalTrials.gov study NCT00650767
-
CLINICAL_TRIALS study record update · 2016-11-02Evaluation of Glucocorticoid Sparing Effect in Patients Receiving RoActemra® for Rheumatoid Arthritis in Real Life.
-
CLINICAL_TRIALS study record update · 2016-11-02A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to Anti-TNF Therapy
-
CLINICAL_TRIALS study record update · 2016-11-02A Multi-national, Multi-center Non-interventional Study in Rheumatoid Arthritis (RA) Patients Who Are Treated With Tocilizumab
-
CLINICAL_TRIALS study record update · 2016-11-02F-ACT Trial: Observational Study on Fatigue and Its Evolution During Treatment With Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis in Daily Clinical Practice
-
CLINICAL_TRIALS study record update · 2016-11-02Multicenter REtrospective Study to Evaluate coMpliance to Therapy and Drug survIval of Tocilizumab (TCZ) in patientS With Moderate to Severe actIve rheumatOid Arthritis in routiNe Daily Clinical Practice (REMISSION II Study)
-
CLINICAL_TRIALS study record update · 2016-11-02A Randomized, Double-blind Study of the Effect of Tocilizumab on Reduction in Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to DMARD Therapy